What is it?
Artichoke means leaf extract in supplement evidence
3On supplement labels, Artichoke usually refers to artichoke leaf extract from Cynara cardunculus, often still cited by the synonym Cynara scolymus. That is different from eating artichoke hearts or flower heads. The leaf extract contains phenolic acids such as cynarin and chlorogenic-acid derivatives, but those markers do not make all extracts interchangeable.
What the human studies actually measured
5A placebo-controlled study enrolled 247 people with functional dyspepsia, meaning persistent upper-digestive discomfort, and reported a greater improvement in symptom and quality-of-life scores with its specific extract. This selected patient population does not establish benefits in healthy adults.
Names, aliases and forms
Mechanisms of action
Bile flow, digestion and polyphenols explain most hypotheses
8A small human experiment investigated bile secretion after artichoke extract. This is physiological evidence, not evidence of improved thinking. Bile-flow activity is also relevant to the targeted biliary contraindications.
Potential effects and evidence map
Human digestive and lipid studies do not establish a cognitive benefit. A six-week placebo-controlled leaf-extract trial assessed digestive symptoms, while pooled lipid studies report mixed outcomes across markers. The cognitive evidence grade is E because these endpoints cannot substantiate focus or memory effects. Short-term oral leaf-extract use has a minimal healthy-adult base risk; gastrointestinal tolerability and specific biliary, allergy and pregnancy cautions are addressed separately.
Digestive and lipid outcomes do not establish long-term brain benefits.
No reliable human evidence supports artichoke leaf extract for focus or attention.
No direct human memory or learning benefit is established for artichoke leaf extract.
Typical dosages and timing
The digestive trial used two 320 mg extract units three times daily. The card range also includes the EMA daily amount for a soft extract of fresh leaves (15-30:1, water); other EMA preparations use different amounts. These are preparation-specific contexts, not a general dose or a cognitive-dose recommendation.
Timing & effect horizon
The repeated-use trial window does not establish an acute onset, a whole-extract The time for blood levels to fall by half during the final elimination phase.Source, or the duration of a single dose. A cognitive onset or evidence-based cycling schedule is not established.
Safety, side effects and risk profile
Mild diarrhea, abdominal cramping, nausea and heartburn have been reported; frequency is unknown.
The EMA monograph reports no drug interactions; dedicated interaction evidence remains limited.
EMA lists bile-duct obstruction, cholangitis, liver disease, gallstones and other biliary disorders requiring supervision as contraindications.
EMA does not recommend medicinal leaf preparations during pregnancy or breastfeeding because safety data are insufficient.
Evidence is form-specific and mostly non-cognitive; nootropic claims remain uncertain.
Reported effects include mild diarrhea with abdominal cramps, nausea and heartburn; allergic reactions can occur and their frequency is unknown. For generally healthy adults using oral leaf extract over short study windows, these findings support a minimal base-risk label. They do not establish safety for indefinite use.
EMA does not recommend medicinal leaf preparations during pregnancy or breastfeeding because data are insufficient, or in children under 12. This guidance concerns medicinal leaf preparations, not ordinary culinary artichoke.
Legal and regulatory status
As of October 2026, the EU EMA monograph describes traditional medicinal use of specified artichoke leaf preparations for digestive complaints. This is not a cognitive indication or blanket approval of supplements. National authorities license herbal medicines; food-supplement rules and permitted claims depend on the destination market.
Practical buying and quality notes
- Compare leaf extract with leaf extract: record the extraction solvent, drug-to-extract ratio (the starting leaf mass used per unit of extract), and declared marker percentage. An extract ratio is not the percentage of cynarin or chlorogenic acids. Neither marker alone proves that two extracts match the preparation studied.3
- Capsule count alone is insufficient: multiply capsules per serving by the declared extract mass per capsule. Compare price per gram only among matching extract specifications. Verify package weight and serving details on the retailer label when the listing name, quantity or normalized price disagree; a displayed zero price per gram is not evidence of a free or best-value product.3
FAQ
Do lipid-study results apply to every marker?
4No. The 2021 pooled extract studies reported differences in total cholesterol, LDL and triglycerides, but no significant HDL effect. Juice was analyzed separately. These marker outcomes do not establish cognitive benefits or interchangeable products.
How should I compare an artichoke dosage label?
5Start with the exact extract specification and the total daily extract amount, not the equivalent weight of starting leaves. The documented trial schedule above is context for a particular preparation; it is not a universal serving recommendation.
Is artichoke food the same as artichoke leaf extract?
3No. Food artichoke, leaf tea, powder, tincture, and standardized leaf extract differ in plant part, concentration, marker compounds, and study relevance.
Are drug interactions established?
3The EMA monograph lists no reported interactions. This is limited evidence, not proof that every medication combination is safe; multi-ingredient products also require checking their other ingredients.
How long is an artichoke cycle?
5There is no established cognitive cycle. A clinical observation period is not a recommended on/off schedule, and the available studies do not establish indefinite daily-use safety.
References
- NCBI Taxonomy. Cynara cardunculus L., Taxonomy ID 4265. Accessed 2026-06-30.
- PubChem. Cynarin, CID 5281769. Accessed 2026-06-30.
- European Medicines Agency. European Union herbal monograph on Cynara cardunculus L. (syn. Cynara scolymus L.), folium. Accessed 2026-06-30.
- Shahinfar H et al. Effects of artichoke leaf extract supplementation or artichoke juice consumption on lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytotherapy Research. 2021;35:6607-6623.
- Holtmann G, Adam B, Haag S, Collet W, Grunewald E, Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Alimentary Pharmacology & Therapeutics. 2003;18(11-12):1099-1105.
- Giacosa A, Guido D, Grassi M, et al. The Effect of Ginger and Artichoke Extract Supplementation on Functional Dyspepsia: A Randomised, Double-Blind, and Placebo-Controlled Clinical Trial. Evidence-Based Complementary and Alternative Medicine. 2015.
- Lazzini S, Polinelli W, Riva A, Morazzoni P, Bombardelli E. The effect of ginger and artichoke extract supplementation on gastric motility: a pilot randomized study in healthy volunteers. European Review for Medical and Pharmacological Sciences. 2016;20(1):146-149.
- Kirchhoff R, Beckers C, Kirchhoff GM, Trinczek-Gartner H, Petrowicz O, Reimann HJ. Increase in choleresis by means of artichoke extract. Phytomedicine. 1994;1(2):107-115.
- Liu H, Li Y, Jin Y, et al. Effects of different natural products in patients with non-alcoholic fatty liver disease-A network meta-analysis of randomized controlled trials. Phytotherapy Research. 2024;38(7):3801-3824.